Literature DB >> 20146570

Design and test of a 434 MHz multi-channel amplifier system for targeted hyperthermia applicators.

J F Bakker1, M M Paulides, A H Westra, H Schippers, G C Van Rhoon.   

Abstract

PURPOSE: For our head-and-neck hyperthermia (HT) applicator, an amplifier system with full amplitude and phase-control to deliver the radio-frequency signals, was not available. We therefore designed and tested a 433.92 MHz multi-channel amplifier system. SYSTEM DESCRIPTION: The design consists of a direct digital synthesizer (DDS) system that generates 12 phase-controlled coherent 433.92 MHz signals, which are amplified to maximum 200 W output per channel. Directional couplers are placed at the amplifiers to couple a small portion of both forward and reflected signals to gain-and-phase detectors. The power setting is applied with a resolution of 2 W and for the phase it is 0.1 degrees . The channels are sequentially sampled at 100 Hz per channel.
METHODS: We tested the performance of the designed amplifier system by measuring the RF spectrum, power and phase accuracy, and by characterising the feedback control by using highly accurate power and phase meters.
RESULTS: The spurious emission is less than 60 dBc and the first two harmonic frequencies are suppressed more than 45 dB. The measurement accuracy for the power (+/-5%) is valid for at least 20 days after calibration and for the phase (+/-5 degrees ) it is valid for at least 2 months.
CONCLUSIONS: The amplifier system operates according to our design criteria to support targeted HT. It can be used for both our in-house developed superficial and head-and-neck HT applicators or any other HT applicator that works on the same frequency of 433.92 MHz.

Entities:  

Mesh:

Year:  2010        PMID: 20146570     DOI: 10.3109/02656730903341191

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

Review 1.  Microwave tissue ablation: biophysics, technology, and applications.

Authors:  Christopher L Brace
Journal:  Crit Rev Biomed Eng       Date:  2010

2.  Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wall.

Authors:  M Linthorst; A N van Geel; E A Baartman; S B Oei; W Ghidey; G C van Rhoon; J van der Zee
Journal:  Strahlenther Onkol       Date:  2013-04-04       Impact factor: 3.621

3.  Design and Characterization of an RF Applicator for In Vitro Tests of Electromagnetic Hyperthermia.

Authors:  Riccardo Ferrero; Ioannis Androulakis; Luca Martino; Robin Nadar; Gerard C van Rhoon; Alessandra Manzin
Journal:  Sensors (Basel)       Date:  2022-05-10       Impact factor: 3.847

Review 4.  Simulation techniques in hyperthermia treatment planning.

Authors:  Margarethus M Paulides; Paul R Stauffer; Esra Neufeld; Paolo F Maccarini; Adamos Kyriakou; Richard A M Canters; Chris J Diederich; Jurriaan F Bakker; Gerard C Van Rhoon
Journal:  Int J Hyperthermia       Date:  2013-05-14       Impact factor: 3.914

Review 5.  Computational modelling of microwave tumour ablations.

Authors:  Jason Chiang; Peng Wang; Christopher L Brace
Journal:  Int J Hyperthermia       Date:  2013-06       Impact factor: 3.914

Review 6.  Status quo and directions in deep head and neck hyperthermia.

Authors:  Margarethus M Paulides; Gerda M Verduijn; Netteke Van Holthe
Journal:  Radiat Oncol       Date:  2016-02-11       Impact factor: 3.481

7.  Design, Implementation, Evaluation and Application of a 32-Channel Radio Frequency Signal Generator for Thermal Magnetic Resonance Based Anti-Cancer Treatment.

Authors:  Haopeng Han; Thomas Wilhelm Eigentler; Shuailin Wang; Egor Kretov; Lukas Winter; Werner Hoffmann; Eckhard Grass; Thoralf Niendorf
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.